Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin–platinum(II) conjugates
Authors:
- Christian LottnerCLChristian Lottner
- Ruth KnuechelRKRuth Knuechel
- Guenther BernhardtGBGuenther Bernhardt
- Henri BrunnerHBHenri Brunner
- 1 January 2004
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 203 (2) , 171-180
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The present and future of combination chemotherapy in bladder cancerSeminars in Oncology, 2002
- Hematoporphyrin-Derived Soluble Porphyrin−Platinum Conjugates with Combined Cytotoxic and Phototoxic Antitumor ActivityJournal of Medicinal Chemistry, 2002
- Photodynamic therapeutics: basic principles and clinical applicationsDrug Discovery Today, 1999
- Oxaliplatin: A review of preclinical and clinical studiesAnnals of Oncology, 1998
- Photodynamic TherapyJNCI: Journal of the National Cancer Institute, 1998
- Ongoing and unsaid on oxaliplatin: the hopeBritish Journal of Cancer, 1998
- Immortalisation of human urothelial cellsUrological Research, 1995
- Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activityJournal of Cancer Research and Clinical Oncology, 1992
- Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesJournal of Cancer Research and Clinical Oncology, 1991
- Computerized determination of growth kinetic curves and doubling times from cells in microcultureAnalytical Biochemistry, 1990